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Introduction. Respiratory distress are very common in Very-low-birth-weight (VLBW) infants and Myocardial injury may play
a role in the disease outcome. Cardiac troponin T (cTnT) is the most useful marker of injury in adult population, but has not
been extensively studied in this population. Aim. To study the role of cTnT in VLBW infants and its association with clinical
outcomes. Methods. All VLBW infants admitted to our NICU were included in the study. Echocardiography and blood samples
for cTnT determination were collected at 24 and 48 hours of life, and values >0.1ng/mL were considered CTnT-positive values.
Results. A total of 116 neonates had their blood samples collected. The median cTnT concentration within 24 hours was 0.191
(0.1–0.79)ng/mL and within 48 hours was 0.293 (0.1–1.0)ng/mL. A logistic regression analysis showed that PDA, low GA, and use
of dopamine were independently associated with positive cTnT and abnormal Dopplerﬂuxometry and diuretics use had protective
eﬀects and was independently associated with troponin values. Conclusion. We observed a high prevalence of positivecTnT values
in VLBW infants associated with illness severity. Our ﬁndings suggest that cTnT may be a useful and early marker of myocardial
injury in VLBW infants.
1.Introduction
Signiﬁcant therapeutic and technological progress have
occurred in the intensive neonatal care in the last decades,
but the care of very-low-birth-weight (VLBW) newborns
still remains a big challenge. These premature newborns are
very often in critical conditions, are immature, and represent
more than 50% of neonatal deaths [1].
RDS aﬀects close to 50% of the VLBW infants; signs and
symptoms of respiratory and cardiovascular disease are very
similar [2], and decreased myocardial function and low car-
diacoutputarecommoncomplicationsofconditionssuchas
respiratory distress syndrome and perinatal asphyxia [3].
The cardiac troponin T (cTnT) is the best biochemical
marker for myocardial ischemia in adults. Its blood level
increases within two hours after a myocardial infarct and
may remain elevated for two weeks [4]. The initial studies
conducted in children and newborns used less sensitive
assays—of ﬁrst and second generation, and the results
of the cTnT were frequently negative. Most studies that
used the third-generation assays seem more promising and
have shown high levels of cTnT in infants with asphyxia,
respiratory distress, and hypotension although there are still
very few data for very-low-birth-weight infant [5, 6].
We designed this prospective study to assess the role of
cTnT in the ﬁrst 48 hours of life and its association with
clinical outcomes in a population of very-low-birth-weight
infants.
2. Methods
We prospectively studied all infants with birth weight less
than 1500g, admitted to the Neonatal Intensive Care Unit
of Laranjeiras Perinatal Clinic, between January 2004 and
July 2005. Infants with congenital malformation or genetic2 International Journal of Pediatrics
syndromes conﬁrmed by laboratorial and clinic tests were
excluded from the study.
Blood samples (0.3mL) were collected with 24 and 48
hours of life in heparinized syringes, taken to the laboratory
to be stored for further analysis. The biochemical analysis
was conducted via the Immunoassay Elecsys Troponin T
STAT (Roche). We arbitrarily deﬁned a positive test if cTnT
blood levels were >0.1ng/dL.
Echocardiograms were performed in the ﬁrst 72 hours
of life by a cardiologist consultant. The parameters recorded
by the echocardiogram were mild, moderate, or severe
dysfunction, cardiac dilatation, and persistence of ductus
arteriosus.
Clinical data of prenatal care, multiparity, hypertension,
diabetes, steroid use, fetal distress, prolonged rupture of
membranes (more than 24 hours), perinatal infection, and
type of delivery were recorded. Neonatal variables included
Apgar scores, birth weight, gestational age, CRIB, and
SNAPPE-II, as well as need for resuscitation in the delivery
room.
We followed infants up to discharge and registered most
important neonatal morbidities: RDS, pneumonia, use of
surfactant, need of oxygen, length of mechanical ventilation,
duration of nasal CPAP, hypotension and persistence of
ductus arteriosus, use of indomethacin, use of inotropic
drugs (dopamine, dobutamine) and diuretics, the presence
of infection at admission, and antibiotic use. For statistical
analysis we used the t-test, Non-parametric tests, chi-square
and logistic regression.
The study was approved by the Ethics Committee Review
Board of the Institution.
3. Results
Between January 1st, 2004, and July 31st, 2005, 156 pre-
term infants with less than 1500g were admitted to the high-
risk nursery of Laranjeiras Perinatal Clinic. We excluded 37
infants due to death before 24 hours of life and congenital
malformations. Additional 3 infants were excluded because
we were unable to obtain troponin values. Therefore, the
prospective study was conducted in 116 patients within this
period.
The main maternal morbidities were arterial hyperten-
sion (41.2%), multiple gestations (24.4%), and the pro-
longed rupture of membranes (17.6%). Infection related to
premature birth was found in 12.7% of the patients. The use
of pre-natal steroids was a common practice (76.3%), and
maternal Dopple rﬂuxometry was abnormal in 56 patients
(47.5%).
Mean Apgar scores at 1 and 5 minutes were 6.2 ± 2.1
and 8.3 ± 1.1, respectively. A total of 95 newborns (80.5%)
required resuscitation in the delivery room. The ventilation
with positive pressure (VPP) was the most used procedure,
followed by orotracheal intubation (36.4%). Seventy-eight
preterm infants (65.5%) presented RDS, and surfactant was
used in 58% of cases. Nasal constant positive airway pressure
(CPAP) was used in 73.5% of VLBW infants, for 11.3 ± 10.6
days and median of 8 days. A total of 95 infants required
oxygen therapy with a median of 12 days of therapy.
Table 1: Main Characteristics of the Studied Population (n = 116).
Birth weight (g) 1050 ±306
Gestational age (weeks) 29.2 ±2.3
CRIB 4.1 ±3.9
SNAPPE 22.2 ±2.4
Mechanical ventilation 61.9%
Persistence of Ductus Arteriosus 55.5%
Use of Dopamine 34.5%
Use of Dobutamine 37%
Early sepsis 23.5%
Deaths 6.7%
VPP = Ventilation with positive pressure.
Sixty infants (55.5%) had a diagnosis of PDA; among
those, 45.4% were treated with indomethacin and 10.1% had
the ductus surgically ligated.
A total of 86 patients had an echocardiogram done
in the ﬁrst week of life. Severe dysfunction was found in
5.9%, moderate dysfunction in 5%, and mild dysfunction
in 13.5%; and 35.3% presented cardiac overload. Pulmonary
hypertension was diagnosed in 9.2% of patients.
The mean hospital stay was 62.7±36.1 days with median
of 58 days.
Table 1 shows characteristics of the studied population.
One hundred and sixteen samples were obtained within
24 hours (70 samples with values ≤0.10 or undetectable).
At 48 hours, we obtained 102 samples (57 samples with
values ≤0.10 or undetectable). For the positive samples
(values >0.10), the median cTnT at 24-hour was 0.193 (0.1–
0.79ng/mL) and at 48 hours it was 0.293 (0.1–1.0ng/mL).
We used the 24-hour results of cTnT in the comparisons
below. Several factors were associated to the increase of cTnT
in the univariate analysis. Tables 2 and 3 illustrate the main
categorical and continuous variables studied.
3.1. Multivariate Analysis: Logistic Regression. We conducted
a logistic regression analysis and included in the model all
variables included in the univariate analysis and considered
the cardiac troponin T as dependent variable. Among the
regression models tested, we chose the one that seemed more
adequate, both from the statistical and biological standpoint.
A patent ductus arteriousus and dopamine use increased
the chance of a newborn presenting positive cTnT in 3.6
(0.95–13.3) and 5.68 (1.5–20.8) times, respectively. On the
other hand, the presence of abnormal Doppler and diuretic
use reduced the chance of a newborn presenting positive
cTnT in 0.27 (0.09–0.7) and 0.12 (0.02–0.5), respectively.
The increase in the gestational age of the newborn has a
protective eﬀect with an odds ratio of 0.65 (0.5–0.8).
4. Discussion
Cardiac troponin T and I (cTnT, cTnI) are accepted as the
gold standard assay for diagnosis of myocardial infarction
in adults. In the last decade a large number of publicationsInternational Journal of Pediatrics 3
Table 2: Neonatal variables versus cardiac troponin T results.
Variables Troponin (−) n = 70 Troponin (+) n = 46 P value
Weight (g) 1124 ±292 953 ±301 P<0.003
GA (weeks) 30 ±2.02 8 ±2.2 P<0.01
CRIB (Me) 3.1 ±3.45 .5 ±4.3 P<0.001
SNAPPE (Me) 18.5 ±16.42 7 ±17.4 P<0.01
Apgar 1min (Me) 6.7 ±1.95 .3 ±2.2 P<0.01
Apgar 5min (Me) 8.5 ±1.07 .9 ±1.3 P<0.01
Days on MV 3.91 ±9.11 2 .5 ±20.1 P<0.01
Days on CPAP 5.3 ±7.91 2 .9 ±12.2 P<0.001
Total Time of O2 16.1 ±25.43 7 .3 ±43.1 P<0.002
Days in hospital 54.2 ±27.97 5 .14 ±43.7 P<0.006
Table 3: Neonatal variables versus cardiac troponin T results.
Variables Troponin (−) Troponin (+) P value
Prenatal steroids 74% 77% P<0.9
Abnormal Doppler 54% 37% P<0.12
EOT (delivery room) 25% 53% P<0.005
DMH 55% 80% P<0.01
Use of surfactant 45% 76% P<0.002
Hypotension 24% 34% P<0.30
PDA 42% 74% P<0.01
Use of indomethacin 34% 60% P<0.01
Use of dopamine 24% 52% P<0.004
Use of dobutamine 27% 54% P<0.005
Use of diuretics 42% 58% P<0.13
Cardiac dysfunction 15% 40% P<0.03
Cardiac overload 28% 47% P<0.05
conﬁrmed the clinical usefulness of troponin T in patients
with acute coronary syndrome establishing the diagnosis of
ischemia, myocardial necrosis, and the prognosis of acute
myocardial infarct. Due to the absolute speciﬁcity of cTnT
regarding the myocardial tissue and its high sensitivity,
even in microscopic regions, for myocardial necrosis, the
American College of Cardiology and the European Society
of Cardiology recommended cardiac troponins as the best
biological markers for myocardial infarct [4].
There are several studies published on the behavior of
cTnT in newborns, in diﬀerent clinical situations, and its
value in diagnosing cardiovascular dysfunction. Adamcov´ a
et al. studying the cTnT in the blood cord of newborns
suggested that its increase would indicate fetal distress and
myocardialcompromise.Theseauthorsevaluatedcordblood
cTnT in 15 healthy term newborns and found plasma
concentrations of 0.05 ± 0.04ng/mL in 10 of the 15 infants
studied. Among these, 5 showed higher concentrations of
cTnT (0.19 ±0.07ng/mL) [5].
In 2000, Trevisanuto et al. described high cTnT con-
centrations in preterm infants with respiratory distress and
suggested that it was due to myocardial damage. They
also observed a signiﬁcant relationship of troponin T levels
with the use of vasopressors, mechanical ventilation, and
high oxygenation index in patients with respiratory distress
syndrome. The mean plasma troponin was 0.38ng/mL
in patients with respiratory distress versus 0.13ng/mL in
patients without respiratory distress (P<0.01) [2].
Thesesameauthors,inasubsequentstudy,comparedthe
cTnT, cTnl, and CKMB concentrations in the blood cord of
85 healthy full-term newborns and in blood samples of their
mothers’ right after birth. The concentrations of cTnT and
cTnl were higher than the detection limit in 2 (2.3%) and 41
(48.2%), respectively. Two mothers (2.3%) had cTnT levels
higher than the detection limit; none showed increase in the
cTnl levels. These authors concluded that cTnT in the blood
cordisoftenabovethedetectionlimitatbirth,whilethecTnl
is more often undetectable and comparable to that of healthy
mothers. Therefore, these cardiac regulatory proteins are of
neonataloriginandarenotinﬂuencedbymaternallevels[6].
Several publications have attempted to correlate in-
creased cTnT with other markers of myocardial dysfunction
and echocardiographic abnormalities. Cruz et al. studied
27 ELBW infants and measured cTnt in the ﬁrst 48 hours
of life. They observed increased levels in infants with low
Apgar scores and requiring inotropic support. cTnT did not
correlate with simultaneous echocardiographic measures of
cardiac function [7]. Costa et al. And Rajakumar et al. in two4 International Journal of Pediatrics
separate studies found a correlation between increased cTnT
and signs of myocardial damage in infants with perinatal
asphyxia [8, 9].
More recently El-Khuﬀash et al. developed a predic-
tive model using echocardiographic data, cTnT, B-type
natruretic peptide, and a PDA scoring system in 60 infants
with less than 32 weeks and less than 1500g, who were fol-
lowed until two years of age. They concluded that the use of
biochemical markers and the PDA scoring system may pro-
vide a better approach to the management of PDA in the ﬁrst
48hoursoflife,withimprovedintactlongtermsurvival[10].
Our study was conducted with the aim of characterizing
the behavior of the cTnT in the very-low-birth-weight
newborn. We conducted prospective measurements of cTnT
using third-generation assay method, for all newborns
admittedtoaneonatalNICU,foreighteenmonths,inaseries
ofnonselectedpatientsandobservedincreasedvaluesin40%
of the infants, according to our deﬁnition.
We recorded clinical events and perinatal morbidity in
this group, looking for associations with the cTnT levels.
Measurements were made between 24 and 48 hours of life,
based on adult data after a myocardial injury. The value of
0.1ng/mL for a cutoﬀ was chosen according to the studies
conducted in adults by Alpert et al., Ohman et al., and
Costa et al. in newborns [4, 7, 8].
We found an association of increased cTnT values
with low birth weight and gestational age and a positive
association with several variables related to illness severity
(Table 3).
Similar to our study, Clark et al. studied a total of
162 newborns (113 healthy and 49 sick) and observed
more elevated values of cTnT in sick preterm. A multiple
regression analysis demonstrated that the rise of cTnT was
associated to the need of respiratory support and to the use
of inotropic drugs [3].
Szymankiewicz et al. studied 39 asphyxiated newborn
versus 44 nonasphyxiated newborns and tried to relate the
cTnT to echocardiographic ﬁndings of myocardial damage.
The cTnT was measured within 12 and 24 hours of life. The
asphyxiated infants had higher levels of cTnT (0.141 versus
0.087ng/mL) than the nonasphyxiated infants (P<0.01)
[11].
In our study, two variables related to asphyxia showed
a positive association with cTnT: the need for intubation in
the delivery room and the mean Apgar scores of 1st and 5th
minute. Our ﬁndings are similar to many other studies that
suggested a positive association of cTnT and asphyxia in the
neonatal period [2, 3, 8–10].
We performed a logistic regression analysis adjusting for
neonatal morbidities and severity scores. The best model
showed that an abnormal maternal doppler and the use of
diuretics had a protective eﬀect, while low gestational age,
the persistence of ductus arteriosus, and the use of dopamine
were associated with a positive cTnT.
The frequency of maternal arterial hypertension and
changes in the Doppler ﬂuxometry was high in this popula-
tion (42% and 47%). These are the most common maternal
risk factors for elective interruption of pregnancy. Abnormal
Doppler ﬂuxometry, when conjugated with intrauterine
growth retardation, is associated to adverse neonatal out-
come. However, in the absence of growth retardation, pre-
mature delivery may render better fetus and so a protective
eﬀect.
Previous publications have already related increased
cTnTtoapatentductusarteriousus.El-KhuﬀashandMolloy
studied 80 infants with 28-week median gestational age and
observed increased cTnT levels in infants with an open
ductus which decreased after ductal closure [12].
Important hemodynamic changes may be related to
an open ductus arteriousus. There is frequently atrial and
ventricular overload and a drop of diastolic blood pressure
causing so-called blood ﬂow steel. The blood that ﬂows in
the descending aorta during systole comes back through the
patent channel towards the pulmonary artery. Large shunts
mayleadtomorethan50%returnofbloodinthedescending
aorta, causing hypoperfusion of all systemic arteries, includ-
ing the coronary arteries. It is possible that the coronary
hypoperfusion will lead to myocardial ischemia, some degree
of necrosis and increased cTnT values. Improvement in
cardiac overload with a patent ductus may also explain the
protective eﬀect of diuretics [13].
The eﬀect of gestational age is still a controversial issue.
Diﬀerent from our ﬁndings, previous studies did not show
increased cTnT values infants with lower gestational age
[3, 10, 12, 14]. Most studies had smaller numbers of VLBW
infants, and very few babies below 28 of weeks gestation. In
a more recent series from our institution, not published yet,
including only babies with less than 1000g, we have also not
foundarelationshipbetweencTnTvaluesandgestationalage
suggesting that these diﬀerences may be population related
[15].
Our study is the largest series of very-low-birth-weight
newborns studied, with a third-generation cTnT assay. The
predominant proﬁle associated with a positive troponin test,
was that of an immature baby, intubated in the delivery
room, with respiratory distress, and requiring vasoactive
drugs.
Our ﬁndings conﬁrm previous observations and suggest
t h a tc T n Tm a yb eav e r yu s e f u la n de a r l ym a r k e ro fm y o c a r -
dial injury in very-low-birth-weight newborn infants.
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